The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $11.93 in the prior trading day, Sotera Health Co (NASDAQ: SHC) closed at $11.69, down -2.01%. In other words, the price has decreased by -$2.01 from its previous closing price. On the day, 0.75 million shares were traded. SHC stock price reached its highest trading level at $12.05 during the session, while it also had its lowest trading level at $11.62.
Ratios:
Our goal is to gain a better understanding of SHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 73.49. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 5.81 whereas as Long-Term Debt/Eq ratio is at 5.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 06, 2024, initiated with a Neutral rating and assigned the stock a target price of $14.
On May 21, 2024, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $13.
Citigroup Upgraded its Neutral to Buy on April 03, 2024, whereas the target price for the stock was revised from $18 to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 06 ’24 when WARBURG PINCUS & CO. sold 15,000,000 shares for $15.03 per share. The transaction valued at 225,450,000 led to the insider holds 73,822,952 shares of the business.
WARBURG PINCUS & CO. sold 15,000,000 shares of SHC for $225,450,000 on Sep 06 ’24. The Director now owns 73,822,952 shares after completing the transaction at $15.03 per share. On Sep 06 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 10,000,000 shares for $15.03 each. As a result, the insider received 150,300,000 and left with 49,215,301 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 3381835008 and an Enterprise Value of 5386387456. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 75.18, and their Forward P/E ratio for the next fiscal year is 13.92. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 8.18. Its current Enterprise Value per Revenue stands at 4.895 whereas that against EBITDA is 10.735.
Stock Price History:
The Beta on a monthly basis for SHC is 1.92, which has changed by 0.0050547123 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.08, while it has fallen to a 52-week low of $10.71. The 50-Day Moving Average of the stock is -9.12%, while the 200-Day Moving Average is calculated to be -15.80%.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 1270530 shares per day over the last 10 days, according to various share statistics. A total of 283.47M shares are outstanding, with a floating share count of 152.40M. Insiders hold about 46.24% of the company’s shares, while institutions hold 50.21% stake in the company. Shares short for SHC as of 1741910400 were 9722720 with a Short Ratio of 9.08, compared to 1739491200 on 8403395. Therefore, it implies a Short% of Shares Outstanding of 9722720 and a Short% of Float of 7.550000399999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Sotera Health Co (SHC) is underway, with the input of 9.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.18, with high estimates of $0.19 and low estimates of $0.18.
Analysts are recommending an EPS of between $0.78 and $0.72 for the fiscal current year, implying an average EPS of $0.74. EPS for the following year is $0.84, with 8.0 analysts recommending between $0.89 and $0.81.
Revenue Estimates
8 analysts predict $245.13M in revenue for the current quarter. It ranges from a high estimate of $249.22M to a low estimate of $242M. As of the current estimate, Sotera Health Co’s year-ago sales were $248.18MFor the next quarter, 8 analysts are estimating revenue of $280.94M. There is a high estimate of $286.95M for the next quarter, whereas the lowest estimate is $278.82M.
A total of 8 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.13B, while the lowest revenue estimate was $1.12B, resulting in an average revenue estimate of $1.13B. In the same quarter a year ago, actual revenue was $1.1BBased on 8 analysts’ estimates, the company’s revenue will be $1.2B in the next fiscal year. The high estimate is $1.21B and the low estimate is $1.19B.
